These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5003621)

  • 61. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):667-73. PubMed ID: 4895430
    [No Abstract]   [Full Text] [Related]  

  • 62. Bleomycin (NSC-125066): phase I clinical study.
    Sonntag RW
    Cancer Chemother Rep; 1972 Apr; 56(2):197-205. PubMed ID: 4114485
    [No Abstract]   [Full Text] [Related]  

  • 63. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
    Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
    Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
    [No Abstract]   [Full Text] [Related]  

  • 64. Leukemia after therapy with alkylating agents for childhood cancer.
    Tucker MA; Meadows AT; Boice JD; Stovall M; Oberlin O; Stone BJ; Birch J; Voûte PA; Hoover RN; Fraumeni JF
    J Natl Cancer Inst; 1987 Mar; 78(3):459-64. PubMed ID: 3469460
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phase I clinical trial of a single-dose and two weekly schedules of ICRF-159 (NSC-129943).
    Creaven PJ; Cohen MH; Hansen HH; Selawry OS; Taylor SG
    Cancer Chemother Rep; 1974; 58(3):393-400. PubMed ID: 4601669
    [No Abstract]   [Full Text] [Related]  

  • 66. Further clinical studies of trimethylpurin-6-ylammonium chloride (NSC-51095) in malignant disease with special emphasis on cancer of urinary bladder.
    Phillips RW
    Cancer Chemother Rep; 1970 Jun; 54(3):181-5. PubMed ID: 4947750
    [No Abstract]   [Full Text] [Related]  

  • 67. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
    Slack NM; Jones R
    Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
    [No Abstract]   [Full Text] [Related]  

  • 68. Early-onset leukopenia and severe thrombocytopenia following doxorubicin chemotherapy for tonsillar squamous cell carcinoma in a dog.
    Henry CJ; Brewer WG; Stutler SA
    Cornell Vet; 1993 Apr; 83(2):163-8. PubMed ID: 8467702
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors.
    Altman SJ; Metter GE; Nealon TF; Weiss AJ; Ramirez G; Madden RE; Fletcher WS; Strawitz JG; Multhauf PM
    Cancer Treat Rep; 1978 Mar; 62(3):389-95. PubMed ID: 206359
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase 1 studies of porfiromycin (NSC-56410).
    Foley HT; Shnider BI; Gold GL; Matias PI; Colsky J; Miller SP
    Cancer Chemother Rep; 1967 Sep; 51(5):283-93. PubMed ID: 4864580
    [No Abstract]   [Full Text] [Related]  

  • 71. Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma.
    Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; O'Connell MJ; Frytak S
    Cancer Treat Rep; 1976 Nov; 60(11):1681-2. PubMed ID: 1021239
    [No Abstract]   [Full Text] [Related]  

  • 72. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
    Kholodnyi MD; Mindlin SS
    Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329
    [No Abstract]   [Full Text] [Related]  

  • 73. Cytosine arabinoside (NSC-63878) in the treatment of epidermoid carcinomas of the head and neck.
    Papac RJ; Fischer JJ
    Cancer Chemother Rep; 1971 Apr; 55(2):193-7. PubMed ID: 5118688
    [No Abstract]   [Full Text] [Related]  

  • 74. Study of Leo-1031 (NSC-134087) in lymphocytic lymphoma and chronic lymphocytic leukemia.
    Kaufman JH; Hanjura GL; Mittelman A; Aungst CW; Murphy GP
    Cancer Treat Rep; 1976 Mar; 60(3):277-9. PubMed ID: 946596
    [No Abstract]   [Full Text] [Related]  

  • 75. [A clinical study of N-nitrosomethylurea].
    Vermel' EM; Korman NP; Milonov BV; Evseenko LS; Orlova RS
    Vopr Onkol; 1970 May; 16(5):31-7. PubMed ID: 4915916
    [No Abstract]   [Full Text] [Related]  

  • 76. Drug-induced thrombocytopenia.
    Gynn TN; Messmore HL; Friedman IA
    Med Clin North Am; 1972 Jan; 56(1):65-79. PubMed ID: 4550194
    [No Abstract]   [Full Text] [Related]  

  • 77. Phase II study of 6 -methylpregn-4-ene-3,11,20-trione (NSC-17256).
    Ramirez G; Weiss AJ; Rochlin DB; Bisel HF
    Cancer Chemother Rep; 1971 Jun; 55(3):265-8. PubMed ID: 5115847
    [No Abstract]   [Full Text] [Related]  

  • 78. Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.
    DeConti RC; Kaplan SR; Calabresi P
    Blood; 1972 May; 39(5):602-9. PubMed ID: 5067305
    [No Abstract]   [Full Text] [Related]  

  • 79. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R; Brugarolas A; Hansen H; Cavalli F; Ryssel H; Siegenthaler P; Clarysse A; Renard J; Kenis Y; Alberto P
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract]   [Full Text] [Related]  

  • 80. The efficacy of animal studies in predicting clinical toxicity of cancer chemotherapeutic drugs.
    Schein P; Anderson T
    Int J Clin Pharmacol; 1973 Nov; 8(3):228-38. PubMed ID: 4203921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.